Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)Jun Masuda, Toshimi Takano|Journal for ImmunoTherapy of Cancer|2023Cited by 65
Validation of the 2018 Japanese Circulation Society (JCS)/Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic CardiomyopathyMasashi Amano, Toru Kubo, Yasushi Sakata et al.|Circulation Journal|2025Cited by 1